Masereel B - Search Results

1

P-glycoprotein inhibition by glibenclamide and related compounds.

Golstein PE, Boom A, van Geffel J, Jacobs P, Masereel B, Beauwens R. Golstein PE, et al. Among authors: masereel b. Pflugers Arch. 1999 Apr;437(5):652-60. doi: 10.1007/s004240050829. Pflugers Arch. 1999. PMID: 10087141

2

Insulinotropic effect of new glibenclamide isosteres.

Ouedraogo R, Nguyen QA, Kane MH, Dunne MJ, Pochet L, Masereel B, Lebrun P. Ouedraogo R, et al. Among authors: masereel b. J Pharmacol Exp Ther. 1999 May;289(2):625-31. J Pharmacol Exp Ther. 1999. PMID: 10215632

3

In vitro and in vivo effects of new insulin releasing agents.

Nguyen QA, Antoine MH, Ouedraogo R, Hermann M, Sergooris J, Pirotte B, Masereel B, Lebrun P. Nguyen QA, et al. Among authors: masereel b. Biochem Pharmacol. 2002 Feb 1;63(3):515-21. doi: 10.1016/s0006-2952(01)00880-2. Biochem Pharmacol. 2002. PMID: 11853702

4

Activation of ATP-dependent K+ channels and inhibition of insulin release: effect of BPDZ 62.

Lebrun P, Antoine MH, Ouedraogo R, Kane C, Dunne M, Hermann M, Herchuelz A, Masereel B, Delarge J, de Tullio P, Pirotte B. Lebrun P, et al. Among authors: masereel b. J Pharmacol Exp Ther. 1996 Apr;277(1):156-62. J Pharmacol Exp Ther. 1996. PMID: 8613913

5

Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase.

Pilotte L, Larrieu P, Stroobant V, Colau D, Dolusic E, Frédérick R, De Plaen E, Uyttenhove C, Wouters J, Masereel B, Van den Eynde BJ. Pilotte L, et al. Among authors: masereel b. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2497-502. doi: 10.1073/pnas.1113873109. Epub 2012 Jan 30. Proc Natl Acad Sci U S A. 2012. PMID: 22308364 Free PMC article.

6

A harmine-derived beta-carboline displays anti-cancer effects in vitro by targeting protein synthesis.

Carvalho A, Chu J, Meinguet C, Kiss R, Vandenbussche G, Masereel B, Wouters J, Kornienko A, Pelletier J, Mathieu V. Carvalho A, et al. Among authors: masereel b. Eur J Pharmacol. 2017 Jun 15;805:25-35. doi: 10.1016/j.ejphar.2017.03.034. Epub 2017 Mar 18. Eur J Pharmacol. 2017. PMID: 28322844 Free PMC article.

7

A pharmacophore model for sulphonyl-urea (-cyanoguanidine) compounds with dual action, thromboxane receptor antagonists and thromboxane synthase inhibitors.

Michaux C, Dogné JM, Rolin S, Masereel B, Wouters J, Durant F. Michaux C, et al. Among authors: masereel b. Eur J Med Chem. 2003 Jul-Aug;38(7-8):703-10. doi: 10.1016/s0223-5234(03)00076-x. Eur J Med Chem. 2003. PMID: 12932901

8

BM-573, a dual thromboxane synthase inhibitor and thromboxane receptor antagonist, prevents pig myocardial infarction induced by coronary thrombosis.

Rolin S, Petein M, Tchana-Sato V, Dogne JM, Benoit P, Lambermont B, Ghuysen A, Kolh P, Masereel B. Rolin S, et al. Among authors: masereel b. J Pharmacol Exp Ther. 2003 Jul;306(1):59-65. doi: 10.1124/jpet.102.046607. Epub 2003 Apr 29. J Pharmacol Exp Ther. 2003. PMID: 12721335

9

Design, synthesis, and anticonvulsant activity of 1-(pyrid-3-ylsulfonamido)-2-nitroethylenes.

Masereel B, Wouters J, Pochet L, Lambert D. Masereel B, et al. J Med Chem. 1998 Aug 13;41(17):3239-44. doi: 10.1021/jm981022n. J Med Chem. 1998. PMID: 9703469

10

Coumarin and isocoumarin as serine protease inhibitors.

Pochet L, Frédérick R, Masereel B. Pochet L, et al. Among authors: masereel b. Curr Pharm Des. 2004;10(30):3781-96. doi: 10.2174/1381612043382684. Curr Pharm Des. 2004. PMID: 15579071 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

134 results

Search Page